The Chemspec Europe 2023, an exhibition for the European fine chemicals industry, was successfully held at the Basel Exhibition Center in Switzerland from May 24th to 25th, 2023. Organized by Mack Brooks Exhibitions Ltd., this annual exhibition is highly regarded for its professionalism, authority, and reputation. This edition of the exhibition attracted over 400 companies from around the world, setting a record, and drew the participation of global pharmaceutical collaborators for networking and business discussions. Laviana Pharmaceuticals was invited to attend this prestigious event.

CPHI North America was successfully held at the Pennsylvania Convention Center in Philadelphia, USA, April 25-27, 2023. The exhibition brought together 356 exhibitors from all over the world and present 23 speeches delivered by authoritative guests on site. It attracted a large number of industry elites to join and share with each other and became an annual renowned event of the pharmaceutical industry. Laviana Pharma was invited to appear at the exhibition.

DCAT Week, the annual conference of The Drug, Chemical & Allied Trades Association, was successfully held in New York, USA, from March 20-23, 2023. DCAT Week is the premier business development event for companies in the pharmaceutical R&D and manufacturing and related industry sectors, bringing together many of the world's leading pharmaceutical companies and related professionals. More than 700 member companies from over 50 countries participated in this event, including global biopharmaceuticals and the upstream and downstream industry chains. Laviana Pharma once again attended this event as a member company.

On December 9, 2022, the 2022 China Pharmaceutical R&D Strength Ranking series of lists was announced at the "2022 Conference on High Quality Development of the Health Industry and the 7th China Pharmaceutical R&D Innovation Summit (PDI)". Among hundreds of biopharmaceutical companies, Laviana Pharma was awarded the title of "Top 20 China Pharmaceutical CDMO in 2022".

On July 27th 2022, Laviana Pharma (Tianjin) Co., Ltd. Testing Center has successfully passed the audit of China National Accreditation Service for Conformity Assessment (CNAS) and acquired the laboratory accreditation certificate (Registration No. CNAS L16763). It marks the company has been equipped with technical abilities to carry out testing with conforming to the ISO 17025 system. It also means the company could use CNAS and ILAN in the acceptable range. That are conducive to improve the core competence of the corporation.

On the morning of February 9, Mr. Jia Di, Deputy Secretary of the Party Committee and Mayor of Dongli District, Tianjin, and other comrades from District Government Office, Talent Office, Industry and Information Bureau, Science and Technology Bureau visited Laviana Pharma (Tianjin) Co., Ltd. (hereinafter referred to as "Tianjin Laviana") to see the production and operation situation of the enterprise and help to solve operation problems.